Achromycin

NDA 50266, held by Storz. Tetracycline Hydrochloride.

As of Nov 13, 2026, NDA 50266 (Achromycin), held by Storz, was first approved by FDA on Apr 19, 1957, with 2 approved supplements and 0 published complete response letters.

First approved: Apr 19, 1957
Supplements approved: 2
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 3 submissions below

Date	Submission	Status	Documents
Apr 19, 1957	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Achromycin10MG/GM · ointment;ophthalmic	Tetracycline Hydrochloride	Discontinued

All 3 submissions, including labeling and manufacturing supplements

Date	Submission	Status	Documents
Jan 28, 1993	Supplement 3Manufacturing	Approved	None posted
Nov 18, 1992	Supplement 2Manufacturing	Approved	None posted
Apr 19, 1957	Original application	Approved	None posted

Identifiers

Application: NDA 50266
Drugs@FDA: Overview at FDA
Company: Storz

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters